Stay updated on BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial

Sign up to get notified when there's something new on the BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the expected study record content with a standard error page. This indicates restricted access to the NCT05599191 page.
    Difference
    17%
    Check dated 2026-09-20T01:59:52.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.6 instead of v3.6.5, indicating a new build of the site without changes to the study details.
    Difference
    0.0%
    Check dated 2026-08-29T22:00:54.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now includes expanded metadata signaling regulatory status (FDA-regulated drug and device) and data-sharing plans, plus added keywords/MeSH terms. It also includes PubMed publications, sponsor/investigator details, and updated record dates for better context and traceability.
    Difference
    100%
    Check dated 2026-08-16T01:16:39.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.4 to v3.6.5, indicating a new release of the page. It reflects an administrative/UI version change rather than a modification to the study details.
    Difference
    0.0%
    Check dated 2026-08-08T23:18:10.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, indicating a small backend or template update with no visible changes to the study information.
    Difference
    0.0%
    Check dated 2026-07-25T12:30:34.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The study’s locations were expanded with new sites in the UK, Turkey, South Africa, India, Argentina, and the US, and the total number of locations increased to 200. The record also shows completion with actual dates and an enrollment of 957.
    Difference
    0.7%
    Check dated 2026-07-18T09:25:36.000Z thumbnail image

Stay in the know with updates to BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial page.